Quantum-Si Inc (QSI) Stock Price, Quote & News

Company Profile

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It...

Industry: Medical Devices

Sector: Healthcare

Phone: 866 688 7374

Website: www.quantum-si.com

Address:

29 Business Park Drive, Branford, United States

dachshund36 Aug. 18 at 10:02 PM

$QSI Interesting AI summary of Indeed and glassdoor information on employee perspectives. Probably not representative https://share.google/aimode/Yqb5xeHySodnmeylz

1 · Reply

dachshund36 Aug. 18 at 11:13 AM

$QSI https://optioncharts.io/options/QSI This seems

0 · Reply

USAEquityResearch Aug. 18 at 12:52 AM

$QSI 📊 USAEquityResearch ▲ 0.74 (+0.57%) Trend: Bearish 📉 RSI (14): 47.8 — neutral territory MACD: bullish, above signal line and rising Volume: normal 📌 Key Levels Resistance: 0.84 Support: 0.70 20-MA: 0.77 | 50-MA: 0.86 Educational content only. Not financial advice.

0 · Reply

Blocktatch Aug. 17 at 12:43 PM

$QSI I would like to see a buyout of this company

3 · Reply

MadMaverick Aug. 15 at 5:23 PM

5/5 Watchlist Wins This Week 🎯 If you followed the Weekly Swing Scout setups, here’s what your week looked like: $PLUG caught the $2.08 dip ➡️ +21.88% $CRCL called at $64.50 ➡️ +$11.06/share (+17.15%) $QSI accumulated at $0.790 ➡️ +15.70% $VSTL broke out over $22.07 ➡️ +9.83% $ASPI stayed safe at support ➡️ +5.46% Level-to-level trading strips away the emotion and gives you actionable plans every single week. 📩 Next week’s watchlist drops SUNDAY NIGHT.

1 · Reply

dachshund36 Aug. 15 at 12:45 AM

$QSI Company is simultaneously saying there is a lot more work to do on Proteus and reducing the workforce. Does anyone have details on how that works?

3 · Reply

JungianQuant Aug. 15 at 12:10 AM

$QSI first time long here. sorry if your cost basis is mich higher. I'm sure i woll also be down 90% soon

0 · Reply

Mickf2022 Aug. 14 at 8:25 PM

$QSI Clearly he's no Warren Buffet as you can see and he has a problem with religion..

1 · Reply

GoldenKnightsFan Aug. 14 at 6:32 PM

$QSI Also per gpt,: "The key is that the instrument itself isn't the entire product. QSI is effectively building an application-specific ecosystem around Proteus: Proteus instrument → application-specific library kit → optimized workflow → better sequencing performance → easier customer adoption That can make Proteus much easier to sell. Management explicitly connected this strategy to reducing the amount of optimization customers need to do themselves. And this is particularly important because QSI has identified and qualified more than 250 institutions interested in Proteus across academia, biopharma and industry. The really interesting implication I think this makes Proteus more of a solutions platform than simply a sequencing machine. It potentially creates multiple consumable revenue streams around the same instrument: Instrument + sequencing consumables + application-specific library kits + software/workflows That could increase revenue per customer and customer stickiness.

1 · Reply

GoldenKnightsFan Aug. 14 at 6:27 PM

$QSI Per gpt: "Management said they are moving from a single general-purpose library-prep kit to a suite of application-oriented kits, based on what they've learned from actual Platinum customers. They specifically said the kits could be used individually or in combination to optimize sequencing for specific customer use cases. What does "application-centric" mean? Instead of saying: "Here's our Proteus instrument and one kit—figure out how to use it for your research." QSI is moving toward: "Tell us what you're trying to accomplish, and we'll provide the optimized workflow/kit for that application." For example, they could develop optimized library-prep kits/workflows for things like: Biomarker discovery Antibody/protein characterization AAV/viral research Pathogen research Agricultural/non-human proteomics This is based on their real-world experience with Platinum customers and their observation that different proteins behave differently during library preparation. "

0 · Reply

Market Cap	162.06M
Revenue (ttm)	2.44M
Net Income (ttm)	-101.34M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4,153.28%
Debt to Equity Ratio	0.00

Volume	1,516,700
Avg Vol	3,936,552
Day's Range	N/A - N/A
Shares Out	217.76M
Stochastic %K	9%
Beta	3.24
Analysts	Sell
Price Target	$2.30